Terms: = Uterine cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Staging
23 results:
1. [Assessment of the diagnostic value and prognosis of different detection markers in endocervical adenocarcinoma].
Zhang CN; Liu XY; Li Q; Song YZ; Liu B; Yin J; Yang JH; Zhong L; Sun L; Zhang X; Chen W
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):402-409. PubMed ID: 37188625
[No Abstract] [Full Text] [Related]
2. [Clinicopathological features of stratified mucin-producing neoplastic lesions of the cervix].
Xu H; Wang YM; Zhang J
Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):28-33. PubMed ID: 31914531
[No Abstract] [Full Text] [Related]
3. [Microcystic, elongated and fragmented invasive pattern in endometrial adenocarcinoma: a clinicopathologic analysis of 72 cases].
Hu D; Zhang HJ; Shen WC; Zhu WF; Li L; Lin XD; Lu JP; Zheng XW; Wang C; Zhou XR
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):318-322. PubMed ID: 28468037
[No Abstract] [Full Text] [Related]
4. Morphological, imaging and surgical aspects in endometrial endometrioid adenocarcinoma.
Berceanu C; Stepan AE; MehedinŢu C; Cîrstoiu MM; Ciortea R; Berceanu S; Gheonea IA; Brătilă E
Rom J Morphol Embryol; 2016; 57(3):995-1002. PubMed ID: 28002515
[TBL] [Abstract] [Full Text] [Related]
5. Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroup.
Lee JC; Lu TP; Changou CA; Liang CW; Huang HN; Lauria A; Huang HY; Lin CY; Chiang YC; Davidson B; Lin MC; Kuo KT
Mod Pathol; 2016 Sep; 29(9):1070-82. PubMed ID: 27255164
[TBL] [Abstract] [Full Text] [Related]
6. Neuroendocrine Carcinoma of the Endometrium: A Clinicopathologic Study of 25 Cases.
Pocrnich CE; Ramalingam P; Euscher ED; Malpica A
Am J Surg Pathol; 2016 May; 40(5):577-86. PubMed ID: 26945341
[TBL] [Abstract] [Full Text] [Related]
7. PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort study.
Visser NC; Bulten J; van der Wurff AA; Boss EA; Bronkhorst CM; Feijen HW; Haartsen JE; van Herk HA; de Kievit IM; Klinkhamer PJ; Pijlman BM; Snijders MP; Vandenput I; Vos MC; de Wit PE; van de Poll-Franse LV; Massuger LF; Pijnenborg JM
BMC Cancer; 2015 Jun; 15():487. PubMed ID: 26123742
[TBL] [Abstract] [Full Text] [Related]
8. Immunohistochemical analysis in the diagnosis of uterine myometrial smooth muscle tumors.
Stănescu AD; Nistor E; Sajin M; Stepan AE
Rom J Morphol Embryol; 2014; 55(3 Suppl):1129-36. PubMed ID: 25607395
[TBL] [Abstract] [Full Text] [Related]
9. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
Cai S; Han K
J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
[TBL] [Abstract] [Full Text] [Related]
10. An update on anal neoplasia.
Fléjou JF
Histopathology; 2015 Jan; 66(1):147-60. PubMed ID: 25283345
[TBL] [Abstract] [Full Text] [Related]
11. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic significance of overexpressed p16ink4a in patients with cervical cancer: a meta-analysis.
Lin J; Albers AE; Qin J; Kaufmann AM
PLoS One; 2014; 9(9):e106384. PubMed ID: 25188353
[TBL] [Abstract] [Full Text] [Related]
13. An immunohistochemical panel to distinguish ovarian from uterine serous papillary carcinomas.
Zhang Y; Garcia-Buitrago MT; Koru-Sengul T; Schuman S; Ganjei-Azar P
Int J Gynecol Pathol; 2013 Sep; 32(5):476-81. PubMed ID: 23896709
[TBL] [Abstract] [Full Text] [Related]
14. Primary and secondary leiomyosarcoma of the oral and perioral region--clinicopathological and immunohistochemical analysis of a rare entity with a review of the literature.
Schütz A; Smeets R; Driemel O; Hakim SG; Kosmehl H; Hanken H; Kolk A
J Oral Maxillofac Surg; 2013 Jun; 71(6):1132-42. PubMed ID: 23434173
[TBL] [Abstract] [Full Text] [Related]
15. Recent developments in uterine mesenchymal neoplasms.
Chiang S; Oliva E
Histopathology; 2013 Jan; 62(1):124-37. PubMed ID: 23240674
[TBL] [Abstract] [Full Text] [Related]
16. An evaluation of p16(ink4a) expression in cervical intraepithelial neoplasia specimens, including women with HIV-1.
Nicol AF; Golub JE; e Silva JR; Cunha CB; Amaro-Filho SM; Oliveira NS; Menezes W; Andrade CV; Russomano F; Tristão A; Grinsztejn B; Friedman RK; Oliveira MP; Pires A; Nuovo GJ
Mem Inst Oswaldo Cruz; 2012 Aug; 107(5):571-7. PubMed ID: 22850945
[TBL] [Abstract] [Full Text] [Related]
17. uterine sarcomas: a review.
D'Angelo E; Prat J
Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
[TBL] [Abstract] [Full Text] [Related]
18. Transition of cervical carcinoma in situ to invasive cancer: role of p16 ink4a expression in progression and in recurrence.
Anschau F; Schmitt VM; Lambert AP; Gonçalves MA; Machado DC
Exp Mol Pathol; 2009 Feb; 86(1):46-50. PubMed ID: 19100258
[TBL] [Abstract] [Full Text] [Related]
19. Small cell neuroendocrine carcinoma of the endometrium and laparoscopic staging: a clinicopathologic study of a case and a brief review of the literature.
Bige O; Saatli B; Secil M; Koyuncuoglu M; Saygili U
Int J Gynecol Cancer; 2008; 18(4):838-43. PubMed ID: 17868342
[TBL] [Abstract] [Full Text] [Related]
20. [Association of p16, p53, Ki-67 expressions with high-risk human papilloma virus infection in cervical intraepithelial neoplasia].
Shi J; Zheng JS; Yin F; Hu WW; Huang XJ; Zhou XL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):515-7. PubMed ID: 17545048
[TBL] [Abstract] [Full Text] [Related]
[Next]
